Antiepithelial antibodies in the serum of patients with benign and malignant diseases of the prostate
Ablin, R.J.
Zeitschrift für Immunitatsforschung Experimentelle und Klinische Immunologie 146(1): 8-22
1973
ISSN/ISBN: 0300-872X PMID: 4143163 Document Number: 60373
Document emailed within 1 workday
Related Documents
Romppanen, J.; Haapalainen, T.; Punnonen, K.; Penttilä, I. 2002: Serum sialic acid and prostate-specific antigen in differential diagnosis of benign prostate hyperplasia and prostate cancer Anticancer Research 22(1a): 415-420Kołomecki, K.; Maciaszczyk, P.; Stepień, H.; Cywiński, J.; Cielecka, J.; Stepień, T.; Kuzdak, K. 2006: Evaluation of p53 and soluble Fas ligand (sFasL) serum level concentration as indicators of apoptosis in serum of patients with benign and malignant primary follicular thyroid tumors Endokrynologia Polska 57(4): 320-325
Malivanova, T.F.; Litvinov, S.V. 1990: Antibodies to retroviruses of types C and D in female patients with benign and malignant mammary tumours Acta Virologica 34(1): 19-26
Amayo, A.; Obara, W. 2004: Serum prostate specific antigen levels in men with benign prostatic hyperplasia and cancer of prostate East African Medical Journal 81(1): 22-26
Kalogeraki, A.; Panayiotides, J.; Tamiolakis, D.; Tzardi, M.; Chaniotis, V.; Chalkiadakis, G.; Melissas, J.; Stiftsis, D.; Kanavaros, P.; Delides, G.S. 2000: P53 expression in patients with malignant and benign breast diseases Anticancer Research 20(3a): 1801-1805
Kovarík, J.; Lauerová, L.; Ninger, E.; Munzarová, M.; Feit, J.; Zemanová, D.; Wotke, R. 1983: Evaluation of the LAi test in patients with benign and malignant breast diseases Neoplasma 30(2): 163-167
Scattoni, V.; Raber, M.; Montorsi, F.; Da Pozzo, L.; Brausi, M.; Calori, G.; Freschi, M.; Rigatti, P. 1999: Percent of free serum prostate-specific antigen and histological findings in patients undergoing open prostatectomy for benign prostatic hyperplasia European Urology 36(6): 621-630
Nikolaenkova, V.A.; Alenina, T.V.; Sterliagova, L.I. 1991: Medium-weight molecules in the blood serum of patients with hyperplastic processes in the endometrium and benign and malignant ovarian tumors Akusherstvo i Ginekologiia 10: 56-58
Stankus, P.; Gazárek, F. 1983: Binding of IgG and IgM class antibodies from the serum of patients with ovarian carcinoma to malignant and normal ovaries Ceskoslovenska Gynekologie 48(5): 332-338
Wei, N.R.; Giebel, W. 1987: Optimization of the immunofluorescence test for antibodies in the serum of patients with inner ear diseases Laryngologie Rhinologie Otologie 66(1): 6-10
Breustedt, W.; Giesel, A.; Puhlmann, B. 1989: Serum IgG antibodies to Chlamydia trachomatis in HLA-B-27 positive patients with rheumatic diseases Dermatologische Monatschrift 175(8): 474-478
Hahn, P.; Smith, I.C.; Leboldus, L.; Littman, C.; Somorjai, R.L.; Bezabeh, T. 1997: The classification of benign and malignant human prostate tissue by multivariate analysis of 1H magnetic resonance spectra Cancer Research 57(16): 3398-3401
Du, Z.; Fujiyama, C.; Chen, Y.; Masaki, Z. 2003: Expression of hypoxia-inducible factor 1alpha in human normal, benign, and malignant prostate tissue Chinese Medical Journal 116(12): 1936-1939
Kuznetsov, A.I.; Idel'son, L.I.; Ivanov, A.L.; Mazurov, A.V. 1991: Antithrombocyte antibodies in the serum and on the surface of the thrombocytes in patients with chronic lymphoproliferative diseases Terapevticheskii Arkhiv 63(7): 26-30
Aleksandrov, A.V.; Alekhina, I.I.; Rasem, S.; Gontar', I.P. 2008: Detection of serum catalase antibodies in patients with inflammatory rheumatic diseases by immobilized magnetic sorbents Klinicheskaia Laboratornaia Diagnostika 7: 39-42
Fialová, L.; Bartos, A.; Soukupová, J.; Svarcová, J.; Ridzon, P.; Malbohan, I. 2009: Synergy of serum and cerebrospinal fluid antibodies against axonal cytoskeletal proteins in patients with different neurological diseases Folia Biologica 55(1): 23-26
Puglisi, F.; Cesselli, D.; Damante, G.; Pellizzari, L.; Beltrami, C.A.; Di Loreto, C. 2000: Expression of Pax-8, p53 and bcl-2 in human benign and malignant thyroid diseases Anticancer Research 20(1a): 311-316
Liebe, S.; Erdmann, K.; Jentzen, H.; Arendt, R. 1989: Transpapillary endoprostheses in malignant and benign bile duct diseases Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 44(20): 612-617
Zamcheck, N.; Moore, T.L.; Dhar, P.; Kupchik, H.Z.; Sorokin, J.J. 1972: Carcinoembryonic antigen in benign and malignant diseases of the digestive tract National Cancer Institute Monograph 35: 433-439
Ana Franjević; Pavi, R.ćević; Bubanovi, G.ć 2012: Differences in Initial NSE Levels in Malignant and Benign Diseases of the Thoracic Wall Clinical Laboratory 58(3-4): 245-252